AWHL
Aspira Women's Health Inc.
Price Chart
Latest Quote
$0.45
-0.04 (-8.16%)
Current Price
| Previous Close | $0.49 |
| Open | $0.47 |
| Day High | $0.47 |
| Day Low | $0.43 |
| Volume | 29,996 |
Stock Information
| Shares Outstanding | 43.50M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $19.58M |
| EPS (TTM) | $-0.33 |
| Exchange | OQX |
đ Comprehensive Analysis
Company Data
| Book/sh | $-0.16 |
| Employees | 36 |
Financial Ratios
Returns & Margins
Ownership
| Insider Ownership | 12.41% |
| Institutional Ownership | 0.67% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| PEG | 1.28 |
| P/B | -2.83 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.44 |
| SMA50 | $0.39 |
| SMA200 | $0.44 |
| RSI | 56.52 |
| ATR | 0.0664 |
| Short Float | 0.79% |
| Short Ratio | 0.02 |
| Rel Volume | 0.41 |
Performance History
| Week | -2.17% |
| Month | +18.42% |
| Quarter | +55.17% |
| 6 Months | +28.57% |
| YTD | -28.57% |
| Year | +462.50% |
| 3 Years | -86.32% |
| 5 Years | -99.45% |
| 10 Years | -97.69% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-04 | $0.45 | 29,996 |
| 2026-06-03 | $0.49 | 27,400 |
| 2026-06-02 | $0.54 | 127,300 |
| 2026-06-01 | $0.54 | 93,600 |
| 2026-05-29 | $0.53 | 184,400 |
| 2026-05-28 | $0.46 | 25,200 |
| 2026-05-27 | $0.42 | 95,600 |
| 2026-05-26 | $0.46 | 166,300 |
| 2026-05-22 | $0.41 | 45,000 |
| 2026-05-21 | $0.42 | 58,800 |
| 2026-05-20 | $0.45 | 82,000 |
| 2026-05-19 | $0.38 | 10,300 |
| 2026-05-18 | $0.36 | 90,100 |
| 2026-05-15 | $0.39 | 10,500 |
| 2026-05-14 | $0.39 | 25,300 |
| 2026-05-13 | $0.45 | 95,900 |
| 2026-05-12 | $0.45 | 79,200 |
| 2026-05-11 | $0.42 | 5,900 |
| 2026-05-08 | $0.43 | 55,500 |
| 2026-05-07 | $0.39 | 160,700 |
| 2026-05-06 | $0.39 | 1,300 |
| 2026-05-05 | $0.38 | 54,000 |
About Aspira Women's Health Inc.
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; and OvaWatch, a assist in the initial and periodic clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass. It is also developing OVAinform, a multi-marker test that combines serum proteins, clinical data, and miRNA for assessing the risk of ovarian cancer in women with an adnexal mass; and ENDOinform a multi-marker test program that combines serum proteins, proprietary miRNAs, and clinical data (metadata), for the identification of endometriosis. The company also operates Aspira Labs, a laboratory that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories. The company distributes its products through its national sales force; Aspira Synergy platform; and with marketing and distribution agreements. It has a research agreement with Harvard's Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University of Lodz; and a strategic alliance agreement with Quest Diagnostics Incorporated and The Cleveland Clinic Foundation. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is based in Austin, Texas.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $3,703,000 | $3,892,000 | $3,861,000 | $3,750,000 |
| Cost Of Revenue | $3,703,000 | $3,892,000 | $3,861,000 | $3,750,000 |
| Total Revenue | $9,182,000 | $9,154,000 | $8,184,000 | $6,812,000 |
| Operating Revenue | $9,182,000 | $9,154,000 | $8,184,000 | $6,812,000 |
| Expenses | ||||
| Total Expenses | $25,460,000 | $28,006,000 | $39,322,000 | $39,407,000 |
| Other Income Expense | $3,217,000 | $2,114,000 | $1,236,000 | $981,000 |
| Other Non Operating Income Expenses | $1,871,000 | $485,000 | $-468,000 | $981,000 |
| Net Non Operating Interest Income Expense | $-33,000 | $48,000 | $17,000 | $-48,000 |
| Total Other Finance Cost | $33,000 | $-48,000 | $-17,000 | $48,000 |
| Operating Expense | $21,757,000 | $24,114,000 | $35,461,000 | $35,657,000 |
| Selling And Marketing Expense | $8,146,000 | $7,812,000 | $14,915,000 | $17,086,000 |
| General And Administrative Expense | $10,345,000 | $12,267,000 | $14,629,000 | $13,257,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-13,094,000 | $-16,690,000 | $-29,885,000 | $-31,662,000 |
| Net Interest Income | $-33,000 | $48,000 | $17,000 | $-48,000 |
| Normalized Income | $-14,440,000 | $-18,319,000 | $-31,589,000 | $-31,662,000 |
| Net Income From Continuing And Discontinued Operation | $-13,094,000 | $-16,690,000 | $-29,885,000 | $-31,662,000 |
| Total Operating Income As Reported | $-16,278,000 | $-18,852,000 | $-31,138,000 | $-32,595,000 |
| Net Income Common Stockholders | $-13,094,000 | $-16,690,000 | $-29,885,000 | $-31,662,000 |
| Net Income | $-13,094,000 | $-16,690,000 | $-29,885,000 | $-31,662,000 |
| Net Income Including Noncontrolling Interests | $-13,094,000 | $-16,690,000 | $-29,885,000 | $-31,662,000 |
| Net Income Continuous Operations | $-13,094,000 | $-16,690,000 | $-29,885,000 | $-31,662,000 |
| Pretax Income | $-13,094,000 | $-16,690,000 | $-29,885,000 | $-31,662,000 |
| Special Income Charges | $0 | $1,000,000 | $0 | - |
| Operating Income | $-16,278,000 | $-18,852,000 | $-31,138,000 | $-32,595,000 |
| Gross Profit | $5,479,000 | $5,262,000 | $4,323,000 | $3,062,000 |
| Interest Income | - | $48,000 | $17,000 | - |
| Interest Income Non Operating | - | $48,000 | $17,000 | - |
| Per Share | ||||
| Diluted EPS | $-0.93 | $-1.81 | $-3.45 | $-4.27 |
| Basic EPS | $-0.93 | $-1.81 | $-3.45 | $-4.27 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-17,532,000 | $-20,282,000 | $-32,578,000 | $-32,293,000 |
| Total Unusual Items | $1,346,000 | $1,629,000 | $1,704,000 | - |
| Total Unusual Items Excluding Goodwill | $1,346,000 | $1,629,000 | $1,704,000 | - |
| Reconciled Depreciation | $92,000 | $199,000 | $264,000 | $302,000 |
| EBITDA (Bullshit earnings) | $-16,186,000 | $-18,653,000 | $-30,874,000 | $-32,293,000 |
| EBIT | $-16,278,000 | $-18,852,000 | $-31,138,000 | $-32,595,000 |
| Diluted Average Shares | $14,134,626 | $9,233,306 | $7,769,108 | $7,414,041 |
| Basic Average Shares | $14,134,626 | $9,233,306 | $7,769,108 | $7,414,041 |
| Diluted NI Availto Com Stockholders | $-13,094,000 | $-16,690,000 | $-29,885,000 | $-31,662,000 |
| Gain On Sale Of Security | $1,346,000 | $629,000 | $1,704,000 | - |
| Research And Development | $3,266,000 | $4,035,000 | $5,917,000 | $5,314,000 |
| Selling General And Administration | $18,491,000 | $20,079,000 | $29,544,000 | $30,343,000 |
| Other Gand A | $10,345,000 | $12,267,000 | $14,629,000 | $13,257,000 |
| Other Special Charges | - | $-1,000,000 | - | - |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-2,563,000 | $-2,365,000 | $6,979,000 | $30,172,000 |
| Total Assets | $5,491,000 | $6,262,000 | $17,373,000 | $41,079,000 |
| Total Non Current Assets | $1,308,000 | $982,000 | $1,064,000 | $1,074,000 |
| Other Non Current Assets | $45,000 | $289,000 | $414,000 | $264,000 |
| Current Assets | $4,183,000 | $5,280,000 | $16,309,000 | $40,005,000 |
| Other Current Assets | $1,098,000 | $997,000 | $1,442,000 | $1,624,000 |
| Inventory | $326,000 | $227,000 | $316,000 | $174,000 |
| Receivables | $990,000 | $1,459,000 | $1,245,000 | $1,027,000 |
| Accounts Receivable | $990,000 | $1,459,000 | $1,245,000 | $1,027,000 |
| Allowance For Doubtful Accounts Receivable | $0 | $-15,000 | $-9,000 | $-23,000 |
| Gross Accounts Receivable | $990,000 | $1,474,000 | $1,254,000 | $1,050,000 |
| Cash Cash Equivalents And Short Term Investments | $1,769,000 | $2,597,000 | $13,306,000 | $37,180,000 |
| Cash And Cash Equivalents | $1,769,000 | $2,597,000 | $13,306,000 | $37,180,000 |
| Prepaid Assets | - | - | - | $1,624,000 |
| Debt | ||||
| Net Debt | $352,000 | - | - | - |
| Total Debt | $3,376,000 | $2,852,000 | $3,831,000 | $4,107,000 |
| Long Term Debt And Capital Lease Obligation | $2,526,000 | $1,857,000 | $2,587,000 | $3,067,000 |
| Long Term Debt | $1,278,000 | $1,430,000 | $2,315,000 | $2,718,000 |
| Current Debt And Capital Lease Obligation | $850,000 | $995,000 | $1,244,000 | $1,040,000 |
| Current Debt | $843,000 | $836,000 | $1,167,000 | $980,000 |
| Other Current Borrowings | $229,000 | $166,000 | $403,000 | $201,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,054,000 | $8,627,000 | $10,394,000 | $10,907,000 |
| Total Non Current Liabilities Net Minority Interest | $2,586,000 | $3,508,000 | $4,867,000 | $3,067,000 |
| Derivative Product Liabilities | $60,000 | $1,651,000 | $2,280,000 | $0 |
| Current Liabilities | $5,468,000 | $5,119,000 | $5,527,000 | $7,840,000 |
| Current Notes Payable | $614,000 | $670,000 | $764,000 | $779,000 |
| Payables And Accrued Expenses | $4,618,000 | $4,124,000 | $4,283,000 | $6,800,000 |
| Payables | $2,173,000 | $1,261,000 | $881,000 | $1,501,000 |
| Accounts Payable | $2,173,000 | $1,261,000 | $881,000 | $1,501,000 |
| Equity | ||||
| Common Stock Equity | $-2,563,000 | $-2,365,000 | $6,979,000 | $30,172,000 |
| Total Equity Gross Minority Interest | $-2,563,000 | $-2,365,000 | $6,979,000 | $30,172,000 |
| Stockholders Equity | $-2,563,000 | $-2,365,000 | $6,979,000 | $30,172,000 |
| Retained Earnings | $-531,397,000 | $-518,303,000 | $-501,613,000 | $-471,728,000 |
| Other | ||||
| Ordinary Shares Number | $17,407,120 | $10,645,049 | $8,306,326 | $7,475,916 |
| Share Issued | $17,407,120 | $10,645,049 | $8,306,326 | $7,475,916 |
| Tangible Book Value | $-2,563,000 | $-2,365,000 | $6,979,000 | $30,172,000 |
| Invested Capital | $-442,000 | $-99,000 | $10,461,000 | $33,870,000 |
| Working Capital | $-1,285,000 | $161,000 | $10,782,000 | $32,165,000 |
| Capital Lease Obligations | $1,255,000 | $586,000 | $349,000 | $409,000 |
| Total Capitalization | $-1,285,000 | $-935,000 | $9,294,000 | $32,890,000 |
| Additional Paid In Capital | $528,817,000 | $515,927,000 | $508,584,000 | $501,893,000 |
| Capital Stock | $17,000 | $11,000 | $8,000 | $7,000 |
| Common Stock | $17,000 | $11,000 | $8,000 | $7,000 |
| Long Term Capital Lease Obligation | $1,248,000 | $427,000 | $272,000 | $349,000 |
| Current Capital Lease Obligation | $7,000 | $159,000 | $77,000 | $60,000 |
| Current Accrued Expenses | $2,445,000 | $2,863,000 | $3,402,000 | $5,299,000 |
| Net PPE | $1,263,000 | $693,000 | $650,000 | $810,000 |
| Accumulated Depreciation | $-1,394,000 | $-1,816,000 | $-2,811,000 | $-2,785,000 |
| Gross PPE | $2,657,000 | $2,509,000 | $3,461,000 | $3,595,000 |
| Leases | $68,000 | $52,000 | $721,000 | $721,000 |
| Other Properties | $1,194,000 | $528,000 | $282,000 | $354,000 |
| Machinery Furniture Equipment | $1,395,000 | $1,929,000 | $2,458,000 | $2,520,000 |
| Properties | $0 | $0 | $0 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-12,150,000 | $-15,918,000 | $-31,300,000 | $-27,579,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-12,113,000 | $-15,894,000 | $-31,068,000 | $-27,395,000 |
| Cash Flow From Continuing Operating Activities | $-12,113,000 | $-15,894,000 | $-31,068,000 | $-27,395,000 |
| Operating Gains Losses | $-1,346,000 | $-1,629,000 | $-1,704,000 | $-1,005,000 |
| Investing Activities | ||||
| Capital Expenditure | $-37,000 | $-24,000 | $-232,000 | $-184,000 |
| Investing Cash Flow | $-37,000 | $-24,000 | $-232,000 | $-184,000 |
| Cash Flow From Continuing Investing Activities | $-37,000 | $-24,000 | $-232,000 | $-184,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $8,377,000 | $4,918,000 | $9,000,000 | $48,235,000 |
| Financing Cash Flow | $11,064,000 | $5,216,000 | $7,427,000 | $48,378,000 |
| Cash Flow From Continuing Financing Activities | $11,064,000 | $5,216,000 | $7,427,000 | $48,378,000 |
| Net Other Financing Charges | $1,156,000 | $-731,000 | $-1,325,000 | $-377,000 |
| Net Common Stock Issuance | $8,377,000 | $4,918,000 | $9,000,000 | $48,235,000 |
| Common Stock Issuance | $8,377,000 | $4,918,000 | $9,000,000 | $48,235,000 |
| Other | ||||
| Repayment Of Debt | $-93,000 | $-148,000 | $-261,000 | $-198,000 |
| Issuance Of Debt | $1,901,000 | $1,177,000 | $0 | $0 |
| Interest Paid Supplemental Data | $49,000 | $45,000 | $77,000 | $77,000 |
| End Cash Position | $1,769,000 | $2,855,000 | $13,557,000 | $37,430,000 |
| Beginning Cash Position | $2,855,000 | $13,557,000 | $37,430,000 | $16,631,000 |
| Changes In Cash | $-1,086,000 | $-10,702,000 | $-23,873,000 | $20,799,000 |
| Proceeds From Stock Option Exercised | $-277,000 | $0 | $13,000 | $718,000 |
| Net Issuance Payments Of Debt | $1,808,000 | $1,029,000 | $-261,000 | $-198,000 |
| Net Short Term Debt Issuance | $1,901,000 | $1,177,000 | $0 | - |
| Short Term Debt Issuance | $1,901,000 | $1,177,000 | $0 | - |
| Net Long Term Debt Issuance | $-93,000 | $-148,000 | $-261,000 | $-198,000 |
| Long Term Debt Payments | $-93,000 | $-148,000 | $-261,000 | $-198,000 |
| Net PPE Purchase And Sale | $-37,000 | $-24,000 | $-232,000 | $-184,000 |
| Purchase Of PPE | $-37,000 | $-24,000 | $-232,000 | $-184,000 |
| Change In Working Capital | $697,000 | $225,000 | $-2,799,000 | $1,394,000 |
| Change In Other Current Liabilities | $-52,000 | $-68,000 | $-14,000 | - |
| Change In Payables And Accrued Expense | $494,000 | $-159,000 | $-2,458,000 | $2,248,000 |
| Change In Accrued Expense | $-418,000 | $-539,000 | $-1,838,000 | - |
| Change In Payable | $912,000 | $380,000 | $-620,000 | $2,248,000 |
| Change In Account Payable | $912,000 | $380,000 | $-620,000 | $2,248,000 |
| Change In Prepaid Assets | $-115,000 | $577,000 | $33,000 | $-548,000 |
| Change In Inventory | $-99,000 | $89,000 | $-142,000 | $-144,000 |
| Change In Receivables | $469,000 | $-214,000 | $-218,000 | $-162,000 |
| Changes In Account Receivables | $469,000 | $-214,000 | $-218,000 | $-162,000 |
| Other Non Cash Items | $3,000 | $249,000 | $578,000 | $37,000 |
| Stock Based Compensation | $1,494,000 | $1,724,000 | $2,414,000 | $3,539,000 |
| Asset Impairment Charge | $41,000 | $28,000 | $64,000 | - |
| Depreciation Amortization Depletion | $92,000 | $199,000 | $264,000 | $302,000 |
| Depreciation And Amortization | $92,000 | $199,000 | $264,000 | $302,000 |
| Gain Loss On Investment Securities | $-1,346,000 | $-629,000 | $-1,704,000 | - |
| Net Income From Continuing Operations | $-13,094,000 | $-16,690,000 | $-29,885,000 | $-31,662,000 |
| Gain Loss On Sale Of PPE | - | - | $64,000 | $1,000 |
| Long Term Debt Issuance | - | - | - | $0 |
Fetched: 2026-02-02